- Home
- CNET vs CNSP Comparison
CNET vs CNSP Comparison
Compare CNET & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- CNSP
- Stock Information
- Founded
- CNET 2003
- CNSP 2017
- Country
- CNET Hong Kong
- CNSP United States
- Employees
- CNET N/A
- CNSP N/A
- Industry
- CNET Advertising
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- CNET Consumer Discretionary
- CNSP Health Care
- Exchange
- CNET Nasdaq
- CNSP Nasdaq
- Market Cap
- CNET 4.0M
- CNSP 4.0M
- IPO Year
- CNET N/A
- CNSP 2019
- Fundamental
- Price
- CNET $2.00
- CNSP $8.79
- Analyst Decision
- CNET
- CNSP Strong Buy
- Analyst Count
- CNET 0
- CNSP 1
- Target Price
- CNET N/A
- CNSP $20.00
- AVG Volume (30 Days)
- CNET 449.2K
- CNSP 76.5K
- Earning Date
- CNET 08-14-2025
- CNSP 11-14-2025
- Dividend Yield
- CNET N/A
- CNSP N/A
- EPS Growth
- CNET N/A
- CNSP N/A
- EPS
- CNET N/A
- CNSP N/A
- Revenue
- CNET $7,688,000.00
- CNSP N/A
- Revenue This Year
- CNET N/A
- CNSP N/A
- Revenue Next Year
- CNET N/A
- CNSP N/A
- P/E Ratio
- CNET N/A
- CNSP N/A
- Revenue Growth
- CNET N/A
- CNSP N/A
- 52 Week Low
- CNET $0.96
- CNSP $4.93
- 52 Week High
- CNET $4.53
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- CNET 72.89
- CNSP 56.10
- Support Level
- CNET $1.39
- CNSP N/A
- Resistance Level
- CNET $2.78
- CNSP $8.07
- Average True Range (ATR)
- CNET 0.21
- CNSP 0.47
- MACD
- CNET 0.05
- CNSP 0.07
- Stochastic Oscillator
- CNET 43.89
- CNSP 95.34
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.